<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>101(3)</volume><submitter>Weinhold N</submitter><journal>Haematologica</journal><pagination>e116-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4815741</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.</pubmed_title><pmcid>PMC4815741</pmcid><pubmed_authors>Egerer G</pubmed_authors><pubmed_authors>Blau IW</pubmed_authors><pubmed_authors>Weinhold N</pubmed_authors><pubmed_authors>Seckinger A</pubmed_authors><pubmed_authors>Hielscher T</pubmed_authors><pubmed_authors>Kirn D</pubmed_authors><pubmed_authors>Weisel K</pubmed_authors><pubmed_authors>Salwender H</pubmed_authors><pubmed_authors>Granzow M</pubmed_authors><pubmed_authors>Hose D</pubmed_authors><pubmed_authors>Goldschmidt H</pubmed_authors><pubmed_authors>Jauch A</pubmed_authors><pubmed_authors>Hillengass J</pubmed_authors><pubmed_authors>Bertsch U</pubmed_authors><pubmed_authors>Raab MS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Mar</publication><modification>2025-04-04T08:49:59.635Z</modification><creation>2025-04-04T08:49:59.635Z</creation></dates><accession>S-EPMC4815741</accession><cross_references><pubmed>26611471</pubmed><doi>10.3324/haematol.2015.136929</doi></cross_references></HashMap>